SMAD2 and breast carcinoma: Similarly, overexpression of miR-3613-3p decreased tumor proliferation and migration in TNBC cells via targeting SMAD2 and EZH2, EZH2 like SMAD2/3, significantly promoting cancer cell proliferation in many cancer cells, including breast cancer [197].